Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 76 AL 90

The MICAL family at the Rho-Rab interface: coordinating actin dynamics through oxidation and scaffolding

Micovic K, Olson MF.

Biochem J. 2026 Oct 7;483(10):2035-2053. doi: 10.1042/BCJ20250118.

Levodopa-Responsive Parkinsonism Preceded by Isolated Upper Limb Tremor Associated with PTEN Variant

Gandhi SE, Siripurapu R, Smith A, Kobylecki C.

Mov Disord Clin Pract. 2026 Sep 28:10.1002/mdc3.70844. doi: 10.1002/mdc3.70844. Online ahead of print.

The effects of dual-task training with different task priorities on physical performance and cognitive status in patients with Parkinson's disease: a single-blind, randomized controlled trial

Özcan Gülşen E, Söke F, Gülşen Ç, Tokçaer Bora HA, Tunca Ö.

Neurol Sci. 2026 Sep 29;47(10):820. doi: 10.1007/s10072-026-09442-1.

Cognitive impairment in glaucoma

Udenia H, Midha N, Verma R, Bari A, Dada T.

Indian J Ophthalmol. 2026 Oct 1;74(10):1451-1461. doi: 10.4103/IJO.IJO_3157_25. Epub 2026 Sep 29.

Iatrogenic Large Bowel Perforation Following Image-Guided Pericardiocentesis: A Case Report

Alnuwaiser SJ, Ali PAN, Alsubhi TD, Alzahrani NN.

Am J Case Rep. 2026 Sep 29;27:e953804. doi: 10.12659/AJCR.953804.

Parkinson's disease: Clinical update and new diagnostic and therapeutic approaches

Rábano-Suárez P, Ramírez Sánchez-Ajofrín J, Santos-García D.

Med Clin (Barc). 2026 Sep 29;166(12):107616. doi: 10.1016/j.medcli.2026.107616. Online ahead of print.

Pesticides as hidden modifiers of drug action: Mechanisms and human health implications

Patil GB, Patil MP, Singh SK, Bafna PS, Kim JO, Mutha RE.

Environ Res. 2026 Nov 15;309(Pt 1):125813. doi: 10.1016/j.envres.2026.125813. Epub 2026 Sep 29.

Home-based virtual reality telerehabilitation for people with Parkinson's disease: a scoping review of delivery, supervision and implementation

Naqvi I, Vardhan V, Khatib N.

BMJ Open. 2026 Sep 29;16(9):e119628. doi: 10.1136/bmjopen-2026-119628.

Hexokinase-2-glycolytic overload axis in brain disorders exacerbated by diabetes

Alhujaily M, Rabbani N, Thornalley PJ.

Trends Endocrinol Metab. 2026 Sep 29:S1043-2760(26)00245-6. doi: 10.1016/j.tem.2026.09.006. Online ahead of print.

Lysosomal dysfunction in neurodegenerative disease

Brooker SM, Coukos R, Krainc D.

Nat Rev Neurol. 2026 Nov;22(11):712-730. doi: 10.1038/s41582-026-01262-3. Epub 2026 Sep 29.

Bioinspired Nanomaterials for Parkinson's Disease: Engineering Membrane Interfaces to Overcome the Blood-Brain Barrier and Enable Neuron-Targeted Delivery

Huang Q, Zuo Y, Xie Y, Liu Z, Wang L, Xu H, Yu M, Liu C.

ACS Biomater Sci Eng. 2026 Oct 12;12(10):5276-5302. doi: 10.1021/acsbiomaterials.6c01137.

The eyes and Parkinsonian syndromes

Chen BS, Sandlin DS, Biousse V.

Rev Neurol (Paris). 2026 Nov;182(9):791-798. doi: 10.1016/j.neurol.2026.09.005. Epub 2026 Sep 30.

Differential proteostasis imbalance and the molecular basis of distinct synucleinopathies and tauopathies

Redeker V, Melki R.

Philos Trans R Soc Lond B Biol Sci. 2026 Oct 1;381(1960):20250272. doi: 10.1098/rstb.2025.0272.

Proteostasis (in)action: the role of co-pathologies in neurodegenerative disease

Morley JF.

Philos Trans R Soc Lond B Biol Sci. 2026 Oct 1;381(1960):20250273. doi: 10.1098/rstb.2025.0273.

Cellular and systemic modifiers of alpha-synuclein proteostasis

Couzijn S, Ainslie AP, Herron-Bedoya A, Nollen EAA.

Philos Trans R Soc Lond B Biol Sci. 2026 Oct 1;381(1960):20250275. doi: 10.1098/rstb.2025.0275.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias